Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

ILLUMINA, INC.

(ILMN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/01/2021 03/02/2021 03/03/2021 03/04/2021 03/05/2021 Date
446.5(c) 441.01(c) 416.41(c) 399.61(c) 398.85(c) Last
865 465 753 114 1 130 830 1 268 038 1 177 556 Volume
+1.61% -1.23% -5.58% -4.03% -0.19% Change
More quotes
Financials (USD)
Sales 2021 3 924 M - -
Net income 2021 749 M - -
Net Debt 2021 436 M - -
P/E ratio 2021 80,2x
Yield 2021 -
Sales 2022 4 567 M - -
Net income 2022 913 M - -
Net cash position 2022 163 M - -
P/E ratio 2022 66,0x
Yield 2022 -
Capitalization 58 192 M 58 192 M -
EV / Sales 2021 14,9x
EV / Sales 2022 12,7x
Nbr of Employees 7 825
Free-Float 74,7%
More Financials
Company
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (84.4%): tools and... 
More about the company
Notations Surperformance© of Illumina, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about ILLUMINA, INC.
03/05ILLUMINA  : and R-Pharm Secure Registration for Two Complete IVD Sequencing Plat..
BU
03/04ILLUMINA, INC.  : Other Events (form 8-K)
AQ
03/03ILLUMINA  : Barclays Starts Illumina at Underweight With $325 Price Target
MT
02/19ILLUMINA  : Continued Level of Significant Insider Selling at Illumina (ILMN)
MT
02/19ILLUMINA  : and the University Hospital of Tübingen Evaluate Potential of Whole ..
BU
02/18INSIDER TRENDS : Insider Disposition Eases Back 90-Day Buy Trend at Illumina
MT
02/18INSIDER TRENDS : Illumina Insider Gets Share Award, Exercises Derivative Securit..
MT
02/18INSIDER TRENDS : Illumina Insider Awarded Stock, Exercises Derivative Security, ..
MT
02/18INSIDER TRENDS : Insider at Illumina Gets Share Award, Exercises Derivative Secu..
MT
02/18INSIDER TRENDS : Illumina Insider Awarded Stock, Converts/Exercises Derivative S..
MT
02/18INSIDER TRENDS : Insider at Illumina Awarded Stock, Converts/Exercises Derivativ..
MT
02/18INSIDER TRENDS : Insider at Illumina Awarded Shares, Converts/Exercises Derivati..
MT
02/18INSIDER TRENDS : Insider at Illumina Gets Stock Award, Converts/Exercises Deriva..
MT
02/18INSIDER TRENDS : Insider at Illumina Receives Share Award, Converts/Exercises De..
MT
02/16ILLUMINA  : BTIG Adjusts Price Target on Illumina to $570 From $410, Maintains B..
MT
More news
News in other languages on ILLUMINA, INC.
02/23PLANÈTE BOURSE  : La revue de presse du mardi 23 février 2021
2020ILLUMINA, INC.  : Veröffentlichung des Quartalsergebnisses
2020ILLUMINA, INC.  : publication des résultats trimestriels
2020ILLUMINA  : bietet für Krebstest-Hersteller Grail acht Milliarden Dollar
2020WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
More news
Analyst Recommendations on ILLUMINA, INC.
More recommendations
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 407,39 $
Last Close Price 398,85 $
Spread / Highest target 42,9%
Spread / Average Target 2,14%
Spread / Lowest Target -31,1%
EPS Revisions
Managers and Directors
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Sam A. Samad Chief Financial Officer & Senior Vice President
Jay T. Flatley Executive Chairman
Phillip G. Febbo Chief Medical Officer
Alex Aravanis Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA, INC.8.00%58 192
THERMO FISHER SCIENTIFIC-4.06%175 974
DANAHER CORPORATION-3.48%155 510
INTUITIVE SURGICAL, INC.-13.32%83 977
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.-9.39%72 243
SIEMENS HEALTHINEERS AG8.33%57 970